US equities
|
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SPCX
$158.96
▲+0.00%
TSLA
$370.59
▲+0.00%
SDEV
$7.48
▲+0.00%
AMD
$633.91
▲+0.00%
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SPCX
$158.96
▲+0.00%
TSLA
$370.59
▲+0.00%
SDEV
$7.48
▲+0.00%
AMD
$633.91
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
InMed Pharmaceuticals Inc. - Common Shares
(NQ:
INM
)
1.330
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about InMed Pharmaceuticals Inc. - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular Degeneration
July 24, 2024
Via
CannabisNewsWire
The Rising Importance Of Minor Cannabinoids In The Growing Edible Market
July 19, 2024
The Rising Importance Of Minor Cannabinoids In The Growing Edible Market
Via
News Direct
Topics
Cannabis
BioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Significant Improvements from INM-089 in AMD, Validates INM-901 as Potential AD Treatment
July 11, 2024
Via
Investor Brand Network
7 F-Rated Growth Stocks to Avoid Right Now: June 2024
↗
June 28, 2024
A good rating for growth in the Portfolio Grader doesn't tell the full picture. These are all growth stocks to avoid now.
Via
InvestorPlace
InMed Pharmaceuticals Inc. (NASDAQ: INM) Advances Therapies Targeting Neurodegenerative Diseases
June 14, 2024
Via
Investor Brand Network
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation at Upcoming Emerging Growth Conference
June 11, 2024
Via
Investor Brand Network
Why Smartsheet Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
↗
June 06, 2024
Via
Benzinga
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
June 06, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
June 06, 2024
Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news affecting shares this morning!
Via
InvestorPlace
INM Stock Earnings: InMed Pharmaceuticals Reported Results for Q3 2024
↗
May 14, 2024
InMed Pharmaceuticals just reported results for the third quarter of 2024.
Via
InvestorPlace
CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q3 Fiscal 2024 Financial Results, Business Update
May 14, 2024
Via
Investor Brand Network
Topics
Intellectual Property
InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer's – New Studies Showcase INM-901's Therapeutic Abilities
May 07, 2024
InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer's – New Studies Showcase INM-901's Therapeutic Abilities
Via
News Direct
Why Pinterest Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
↗
May 01, 2024
Via
Benzinga
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
↗
April 24, 2024
Via
Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Welcomes Leading Authority in Alzheimer’s Research to Scientific Advisory Board
April 18, 2024
Via
Investor Brand Network
CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMD
April 16, 2024
Via
Investor Brand Network
InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Favorable Results from INM-901 Preclinical AD Studies
April 04, 2024
Via
Investor Brand Network
TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Receives Notification from NASDAQ of 180-Day Extension
March 21, 2024
Via
Investor Brand Network
InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
↗
February 23, 2024
The Dow Jones index closed higher by over 450 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying
↗
February 22, 2024
The Dow Jones index closed higher by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Financial Numbers for Q2 2024, Corporate Update
February 14, 2024
Via
Investor Brand Network
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names New Chief Financial Officer
February 09, 2024
Via
Investor Brand Network
InMed Pharmaceuticals Has Multiple Milestones Coming Up In 2024, With A Focus On Three Conditions With An Unmet Need
January 26, 2024
--News Direct--
Via
News Direct
InMed Pharmaceuticals Has Multiple Milestones Coming Up In 2024, With A Focus On Three Conditions With An Unmet Need
↗
January 25, 2024
Cannabinoids are having a moment in treating everything from Alzheimer’s to ocular diseases and InMed Pharmaceuticals Inc. (NASDAQ: INM) seems to be at the center of it all.
Via
Benzinga
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO to Present at January Water Tower Research Fireside Chat
January 19, 2024
Via
Investor Brand Network
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Business Update, Milestones
January 16, 2024
Via
Investor Brand Network
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Business Update, Milestones
January 16, 2024
Via
CannabisNewsWire
Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket
↗
December 21, 2023
Shares of BlackBerry Limited (NYSE: BB) moved lower in pre-market trading following the release of third-quarter results.
Via
Benzinga
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Approves Election of Directors During 2023 Annual General Meeting
December 20, 2023
Via
Investor Brand Network
Investment Chief At $48B Global X Forecasts AI Stock Dominance In 2024: Unveils Top Investment Opportunities
↗
December 17, 2023
AI-related stocks including industry leaders like Nvidia (NASDAQ: NVDA), cloud computing, and cybersecurity stand out as "naturals that fit together."
Via
Benzinga
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
